1. Home
  2. NOTV vs BODI Comparison

NOTV vs BODI Comparison

Compare NOTV & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • BODI
  • Stock Information
  • Founded
  • NOTV 1974
  • BODI 1998
  • Country
  • NOTV United States
  • BODI United States
  • Employees
  • NOTV N/A
  • BODI N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • BODI Industrial Machinery/Components
  • Sector
  • NOTV Health Care
  • BODI Industrials
  • Exchange
  • NOTV Nasdaq
  • BODI Nasdaq
  • Market Cap
  • NOTV 46.2M
  • BODI 47.2M
  • IPO Year
  • NOTV 1997
  • BODI N/A
  • Fundamental
  • Price
  • NOTV $1.34
  • BODI $5.85
  • Analyst Decision
  • NOTV Buy
  • BODI Strong Buy
  • Analyst Count
  • NOTV 3
  • BODI 3
  • Target Price
  • NOTV $5.25
  • BODI $13.00
  • AVG Volume (30 Days)
  • NOTV 172.6K
  • BODI 11.4K
  • Earning Date
  • NOTV 08-08-2024
  • BODI 08-06-2024
  • Dividend Yield
  • NOTV N/A
  • BODI N/A
  • EPS Growth
  • NOTV N/A
  • BODI N/A
  • EPS
  • NOTV N/A
  • BODI N/A
  • Revenue
  • NOTV $501,062,000.00
  • BODI $477,489,000.00
  • Revenue This Year
  • NOTV N/A
  • BODI N/A
  • Revenue Next Year
  • NOTV $8.69
  • BODI N/A
  • P/E Ratio
  • NOTV N/A
  • BODI N/A
  • Revenue Growth
  • NOTV N/A
  • BODI N/A
  • 52 Week Low
  • NOTV $1.29
  • BODI $5.71
  • 52 Week High
  • NOTV $11.42
  • BODI $20.00
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 33.17
  • BODI 25.23
  • Support Level
  • NOTV $1.37
  • BODI $6.72
  • Resistance Level
  • NOTV $1.63
  • BODI $6.85
  • Average True Range (ATR)
  • NOTV 0.12
  • BODI 0.32
  • MACD
  • NOTV -0.00
  • BODI -0.04
  • Stochastic Oscillator
  • NOTV 14.71
  • BODI 8.35

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.

Share on Social Networks: